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Abstract: We have previously shown that in HeLa cells treated with a variety of agents 
there is an increase in cell surface peptidase (CSP) activity in those cells undergoing 
apoptosis. The increase in CSP activity observed in UVB-irradiated cells undergoing 
apoptosis was unaffected when the cultures were treated with the aminopeptidase inhibitor 
bestatin, and matrix metalloprotease inhibitor BB3103, but greatly enhanced when treated 
with the caspase 3 inhibitor-DEVD, and reduced in the presence of the poly(ADP-ribose) 
polymerase (PARP) inhibitor-3-aminobenzamide (3AB). Neither 3AB nor DEVD had an 
effect on the gross morphology of the apoptotic cells observed under electron microscopy, 
nor did they have an effect on phosphatidylserine eversion on the cell membrane, or that of 
PARP cleavage. All the agents except for DEVD had no effect on the level of caspase 3 
activity in the cells. The results suggest that other caspases may cleave PARP in these cells. 
Both 3AB and DEVD treatment reduced the level of actin cleavage seen in the apoptotic 
cells. The increase in CSP activity observed in cells undergoing UVB-induced apoptosis 
appears to involve PARP but not caspase 3. 
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1. Introduction 
When a cell is exposed to a lethal dose of a genotoxic agent, it can die by one of two known 
mechanisms, necrosis or apoptosis. These two forms of cell death differ from each other with respect 
to many aspects of cell biology [1–3]. Since the initial landmark observations made by Kerr and  
others [4], numerous studies have been undertaken to elucidate the many processes that occur in cells 
undergoing apoptosis. The gross morphological changes that occur in a cell undergoing apoptosis have 
been well characterised in the literature. One of the early changes observed in an adherent cell 
undergoing apoptosis is its detachment from the substrate [5] followed by the loss of specialised 
membrane structures such as microvilli [6]. The cell then undergoes rounding, shrinkage and blebbing 
before condensation of chromatin is observed in the nucleus. After a period of time the cell fragments 
into apoptotic bodies, which in vivo are engulfed and degraded by phagocytic cells such as 
macrophages [7]. 
Many biochemical changes have been shown to occur in a cell as it undergoes apoptosis. 
Phosphatidylserine inversion on the cell membrane occurs early during apoptosis while that of 
carbohydrates such as fucose occurs later [8,9]. Intracellular proteases such as caspases are activated, 
which result in the cleavage of intracellular proteins such as poly(ADP-ribose) polymerase (PARP), 
DNA-dependent protein kinase (DNA-PK), actin, fodrin and lamin [10,11]. Other proteases that play a 
role in apoptosis include calpains and serine proteases [5,12]. Increased metalloprotease activity on the 
cell membrane has been observed resulting in the shedding of proteins such as CD46, E-cadherin and 
L-selectin from cells undergoing apoptosis [13–16]. 
Enzymes on the plasma membrane such as caspase 1 (or ICE), are activated as the cell undergoes 
apoptosis [10,11]. ICE cleaves IL-1β from its precursor form, which in vivo attracts macrophages to 
engulf these cells as they undergo apoptosis. The mechanisms by which cell surface peptidases (CSP) 
in HeLa cells [17] are activated during apoptosis still remain to be elucidated. This activation could be 
a result of phosphatidylserine inversion in the cell membrane [8,9]. However, this does not appear to 
be the case, as a uniform change in enzyme activity was not observed in these cells as they were 
exposed to a range of apoptotic stimuli [17]. Changes in CSP activity may be related to intracellular 
events occurring as the cell undergoes apoptosis. Caspase 3 cleaves a wide range of proteins including 
PARP, gelsolin and Apaf-1 [10,11], as well as activating caspases 2 and 6 in the cell [18]. The action 
of this and other caspases may be involved in the activation of these proteases. PARP located in the 
nucleus is activated in response to metabolic, chemical, or radiation-induced DNA single strand  
breaks [19,20]. NADH is required by PARP as a substrate for generating ADP-ribose monomers, and 
excessive DNA damage may deplete the cell of its energy reserves, resulting in necrosis [21]. However, 
during apoptosis PARP is cleaved by caspase 3, thereby preventing the NADH depletion, and at the 
same time cell death switches from necrosis to apoptosis [19,20]. It is unknown if PARP cleavage 
plays a role in activating CSP activity. 
In this study, we examined the effect of UVB radiation on HeLa cells, and to elucidate the 
mechanism(s) involved in activating CSP in cells undergoing apoptosis. It is unknown if the activation 
of these peptidases [22] is part of a global response to UV radiation or is only observed in cells 
undergoing apoptosis. CSP activity was increased in UVB-induced apoptotic cells, except in those 
treated with the PARP inhibitor (3-aminobenzamide, 3AB). In general, UVB-induced necrotic cells 
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had significantly reduced levels of CSP activity, while those seen in unirradiated cultures did not. 
From the results of studies undertaken it was concluded that CSP activity was modulated by PARP 
activation but caspase 3 was not involved. 
2. Results 
In an earlier study, we have shown that the levels of cell surface peptidase (CSP) activities were 
increased in apoptotic cells and reduced in necrotic cells compared to that seen in the viable  
UVC-irradiated HeLa cells [17]. In order to be able to separate and collect viable, apoptotic and 
necrotic cells using flow cytometry, the HeLa cells were stained with Hoescht 33342 (H33342) and 
Propidium Iodide (PI) dyes. The cells found in these three regions differed from each other with 
respect to morphology as well as DNA banding patterns [17]. HeLa cell cultures were exposed to 
different doses of either UVB or UVC radiation, and were harvested 20 h post-irradiation. From Figure 1, 
it can be seen that with UVB radiation at <500 Jm−2 there were few apoptotic cells, while at >500 Jm−2 
there were few viable cells. Therefore in order to obtain optimal numbers of all three cell 
subpopulations, a dose of 500 Jm−2 UVB was used. The survival curves of the UVB-irradiated HeLa 
cells were different to that seen in the same cells exposed to UVC radiation [17]. A similar observation 
was also observed in HaCaT cells exposed to either UVB or UVC radiation [23]. 
Figure 1. The dose response curves of HeLa cells exposed to UVB- and UVC-radiation. 
The percentages of the subpopulations [viable (●), apoptotic (▲) and necrotic cells (□)] 
were calculated where the total population represents 100%. The cells were exposed to either 
(A) UVB or (B) UVC radiation. Results expressed are the mean ± SEM of 5–15 samples. 
 
In order to elucidate the mechanism involved in activation of CSP in apoptotic HeLa cells [17], we 
examined the effects of the following agents in UVB-irradiated cells: (a) aminopeptidase inhibitor 
bestatin (10 µM) [24]; (b) matrix metalloprotease inhibitor BB3103 (20 µM) (kindly supplied from 
British Biotech Pharmaceuticals); (c) PARP activation inhibitor 3AB (10 mM) [25,26]; and (d) caspase 
3 inhibitor DEVD (1 µM) [27]. The effects of these agents on the composition of the different cell 
subpopulations in sham- and UVB-irradiated HeLa cell cultures are seen in Figure 2. In general, these 
agents had no effect on the composition of the different cell subpopulations in either irradiated cultures. 
In the unirradiated cultures, those treated with 10 µM bestatin had less viable and more necrotic cells 
than untreated control cultures, while those treated with the cell permeable caspase 3 inhibitor, DEVD, 
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had more viable and less necrotic cells. In the UVB-irradiated cultures bestatin treatment increased the 
number of necrotic cells compared to that seen in untreated irradiated cultures. 
Figure 2. Effect of different agents on the composition of HeLa cell cultures that have 
been exposed to either 0 or 500 Jm−2 UVB radiation. The percentages of the 
subpopulations were calculated where the total population represented 100%, and are 
comprised of viable (□), apoptotic ( ) and necrotic cells (■). The following agents were 
added to the cultures: Nothing (controls), 10 µM Bestatin (Bes), 20 µM BB3103, 10 mM 
3AB and 1 µM DEVD. Results expressed are the mean ± SEM of 5–15 samples. The 
statistical significance of the difference between the control population and the treated 
groups for each subpopulation are represented as * p < 0.05. 
 
2.1. Cellular Protein Content 
The protein content of the apoptotic and necrotic subpopulations of the sorted UVB-irradiated cells 
were less than that of their corresponding viable cohorts (Table 1). The results obtained were similar to 
that seen when HeLa cells were exposed to different apoptotic stimuli [17]. The necrotic cells 
contained approximately one-third of the protein content of their viable cell cohorts in the unirradiated 
cultures. The protein content of the apoptotic cell subpopulation of the unirradiated cultures could not 
be determined due to the low number of cells present. The protein content of the viable subpopulation 
of the UVB-irradiated cultures were approximately 80% of that of the corresponding unirradiated 
cultures except for those cells treated with DEVD (58%). The protein content of the apoptotic 
subpopulation of the UVB-irradiated cultures apart from the controls (83%), was similar to that of their 
corresponding viable cohorts (92–100%). The necrotic cell fraction contained 40–52% of the protein 
content of their viable cohorts. These changes in the protein content of apoptotic and necrotic cells 
were similar to that seen previously [7,17,28]. This reduction in protein content is most likely due to a 
disruption of plasma membrane integrity resulting in the loss of cytosolic proteins [7,28]. 
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Table 1. Effect of different agents on the protein content of different HeLa  
cell subpopulations.  
 Protein Content (mg/107 cells) of Sorted Cell Subpopulations 
Agent Viable 
(V) 
Apoptotic 
(A) 
Ratio 
(A/V) 
Necrotic 
(N) 
Ratio 
(V/N) 
0 J UVB-irradiated cells     
Control 5.8 ± 0.1 (26)   2.1 ± 0.1 z (18) 0.36 
Bestatin (10 µM) 6.0 ± 0.3 (14)   2.2 ± 0.1 z (8) 0.37 
BB3103 (20 µM) 5.5 ± 0.2 (12)   2.1 ± 0.3 z (10) 0.38 
3AB (10 mM) 5.8 ± 0.1 (16)   1.7 ± 0.1 z (10) 0.29 
DEVD (1 µM) 5.5 ± 0.1 (20)   2.0 ± 0.2 z (10) 0.36 
500 J UVB-irradiated cells     
Control 4.8 ± 0.2 (24) 4.0 ± 0.1 z (44) 0.83 1.9 ± 0.1 z (32) 0.40 
Bestatin (10 µM) 4.5 ± 0.6 (8) 4.5 ± 0.2 (14) 1.00 1.8 ± 0.1 z (10) 0.40 
BB3103 (20 µM) 4.2 ± 0.2 (10) 3.9 ± 0.1 (16) 0.93 2.2 ± 0.2 z (12) 0.52 
3AB (10 mM) 4.8 ± 0.3 (16) 4.4 ± 0.1 z (20) 0.92 2.2 ± 0.1 a,z (14) 0.46 
DEVD (1 µM) 3.2 ± 0.2 a (12) 3.1 ± 0.1 a (20) 0.97 1.6 ± 0.2 z (10) 0.50 
The statistical significance of the difference between the level of protein in the control population and the 
treated groups (between groups) are represented as a p < 0.0125 (calculated using Bonferroni’s adjustment for 
multiple comparisons with Student’s t-test), while the differences between the viable vs. the apoptotic or 
necrotic populations within treatment groups are represented as z p < 0.05. 
2.2. Cell Surface Peptidase (CSP) Activity 
In measuring the level of CSP activity in these cells, we used a nonapeptide substrate (called P9) 
that is cognate to the N-terminal cleavage site of TGFα (transforming growth factor-α) [17,22,29]. The 
activity of the “TGFαase”, which cleaves the P9 peptide at the N-cleavage site corresponding to that 
seen in TGFα, produces a P5 fragment, has been shown to be elevated in UV-irradiated  
cultures [17,22,30]. It is generally acknowledged that TACE (tumour necrosis factor α converting 
enzyme) is responsible for the cleavage of TGFα at both its N- and C-terminal cleavage site [31,32], 
though it has been suggested that other enzymes may be involved [33]. In this study we refer to the 
enzyme responsible for the production of the P5 fragment from P9 as TACE.  
The level of CSP activity in the different cell subpopulations can be seen in Tables 2  
(sham-irradiated cells) and 3 (UVB-irradiated cells). Total CSP activity was similar between the viable 
and necrotic subpopulation of unirradiated cells (Figure 3). The main peptidase present on the HeLa 
cell membrane was an aminopeptidase [17,22,30]. In HeLa cells this is not aminopeptidase N [34]. 
This aminopeptidase accounts for between 79–86% total CSP activity in the viable subpopulation of 
the unirradiated cultures, and 64–77% in the necrotic subpopulations (Table 2). CSP activity was not 
measured in the apoptotic subpopulation of the unirradiated cultures, as there were insufficient 
numbers of cells to perform these assays. Of the treatments used in the unirradiated cultures, DEVD 
induced aminopeptidase activity in both the viable and necrotic cell subpopulations, while 3AB 
inhibited activity in the necrotic cells (Table 2). 
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Table 2. Effect of different treatments on cell surface peptidases (CSP) activity in HeLa 
cell subpopulations. Results represent the mean ± SD for 2–10 separate experiments, as 
seen in parantheses.  
 
Cell Population 
P9-Derived Peptide Fragment (pmol/mg cell protein/15 min) 
Treatment P1 P2 P3 P5 
0 µM Bestatin     
Control Viable (10) 139.0 ± 10.9 15.1 ± 1.2 5.1 ± 0.8 7.3 ± 1.2 
 Apoptotic     
 Necrotic (7) 125.4 ± 25.3 26.3 ± 8.7 18.1 ± 3.3 z 21.2 ± 4.6 z 
Bestatin Viable (3) 113.8 ± 9.7 a 29.2 ± 6.1 a 3.7 ± 1.0 8.2 ± 0.7 
(10 µM) Apoptotic     
 Necrotic (2) 111.6 ± 62.6 21.7 ± 9.2 14.9 ± 8.0 14.5 ± 2.5 
BB3103 Viable (2) 104.4 ± 10.2 a 10.2 ± 2.6 4.7 ± 1.5 10.8 ± 6.5 
(20 µM) Apoptotic     
 Necrotic (2) 82.6 ± 60.7 10.6 ± 8.2 a 12.2 ± 5.0 17.6 ± 8.8 
3AB Viable (3) 106.9 ± 23.3 12.9 ± 4.9 5.8 ± 1.3 7.1 ± 0.7 
(1 mM) Apoptotic     
 Necrotic (2) 36.4 ± 24.8 a 15.9 ± 3.0 8.0 ± 3.7 21.8 ± 16.4 
DEVD Viable (4) 172.4 ± 21.8 a 14.3 ± 2.4 3.9 ± 1.3 6.8 ± 2.1 
(1 µM) Apoptotic     
 Necrotic (2) 259.0 ± 76.8 a 33.3 ± 3.7 a 15.2 ± 0.7 a 16.0 ± 12.9 
10 µM Bestatin     
Control Viable (10) 14.5 ± 2.2 38.5 ± 3.3 50.8 ± 3.1 10.2 ± 1.5 
 Apoptotic     
 Necrotic (7) 23.8 ± 3.3 z 17.9 ± 3.2 z 47.8 ± 9.1 22.1 ± 5.2 z 
Bestatin Viable (3) 21.5 ± 4.1 a 39.7 ± 9.1 58.2 ± 12.3 12.1 ± 1.6 
(10 µM) Apoptotic     
 Necrotic (2) 45.0 ± 26.6 a 32.6 ± 19.2 62.2 ± 34.4 23.4 ± 7.5 a 
BB3103 Viable (2) 33.4 ± 22.1 14.1 ± 2.2 a 69.2 ± 36.6 18.1 ± 9.4 
(20 µM) Apoptotic     
 Necrotic (2) 31.1 ± 23.6 8.5 ± 6.4 a 45.9 ± 31.6 18.4 ± 11.5 
3AB Viable (3) 13.9 ± 2.5 30.2 ± 1.8 a 51.5 ± 7.5 12.6 ± 1.6 
(1 mM) Apoptotic     
 Necrotic (2) 21.3 ± 16.2 26.2 ± 18.8 40.8 ± 28.3 20.2 ± 16.0 
DEVD Viable (4) 9.5 ± 2.6 a 42.3 ± 6.6 52.3 ± 6.5 6.4 ± 2.9 a 
(1 µM) Apoptotic     
 Necrotic (2) 23.1 ± 20.3 67.4 ± 1.0 a 151.0 ± 10.8 a 24.2 ± 1.1 a 
The significance of differences between control vs. treated subpopulations are represented as a p < 0.05, while 
that between viable vs. necrotic subpopulations of the control groups are represented by z p < 0.05. 
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Figure 3. Comparison of the level of cell surface peptidases (CSP) activity in the cell 
subpopulations of HeLa cells treated with different agents. The level of aminopeptidase (□) 
and ectopeptidase (■) activity was shown in the cell subpopulations of sham- or 500 Jm−2 
UVB-irradiated cells in the absence (A) or presence of 10 µM bestatin (B). 
 
 
 
The aminopeptidase inhibitor bestatin [24,35] significantly reduced aminopeptidase activity in the 
cells (Tables 2 and 3). As a result, the levels of dipeptidase, tripeptidase and TACE activity were 
increased, with the tripeptidase having the highest activity. We will use the term ectopeptidases to refer 
to dipeptidase, tripeptidase and TACE activity, as these enzymes act at cleavage sites within the P9 
substrate. In general, in the presence of bestatin, the level of CSP activity was similar in the viable 
(108.3–134.8 pmol/mg/15 min) and necrotic cell subpopulations (103.9–265.6 pmol/mg/15 min) of the 
unirradiated cells. A significant increase in tripeptidase activity (316%) was observed in the necrotic 
cell subpopulation of DEVD-treated cells compared to that seen in untreated cultures (Figure 3B).  
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Table 3. Effect of different treatments on CSP activity in UVB-irradiated HeLa cell 
subpopulations. Results represent the mean ± SD for 2–16 separate experiments, as seen in 
parantheses.  
 
Cell Population 
P9-Derived Peptide Fragment (pmol/mg cell protein/15 min) 
Treatment P1 P2 P3 P5 
0 µM Bestatin     
Control Viable (8) 154.1 ± 14.9 21.1 ± 3.5 12.9 ± 5.1 9.9 ± 1.8 
 Apoptotic (16) 275.9 ± 20.6 z 28.8 ± 2.9 z 8.1 ± 1.1 9.7 ± 1.5 
 Necrotic (10) 6.7 ± 1.3 z 5.2 ± 0.9 z 5.1 ± 0.7 z 7.6 ± 1.6 
Bestatin Viable (2) 92.8 ± 40.0 a 14.3 ± 1.2 a 10.7 ± 8.8 8.7 ± 5.6 
(10 µM) Apoptotic (4) 323.4 ± 105.7 59.2 ± 20.3 a 9.0 ± 3.4 8.2 ± 1.2 
 Necrotic (3) 7.2 ± 3.3 8.8 ± 3.1 9.5 ± 3.8 a 1.8 ± 0.4 a 
BB3103 Viable (2) 149.9 ± 5.4 5.9 ± 1.6 a 6.5 ± 2.7 12.6 ± 8.3 
(20 µM) Apoptotic (4) 221.5 ± 22.4 a 7.0 ± 1.0 a 7.5 ± 3.1 15.3 ± 3.9 a 
 Necrotic (3) 5.4 ± 1.5 4.2 ± 1.6 4.0 ± 0.3 6.7 ± 1.7 
3AB Viable (4) 82.4 ± 6.3 a 11.1 ± 0.7 a 4.0 ± 0.7 a 8.4 ± 0.9 
(1 mM) Apoptotic (4) 107.3 ± 10.7 a 13.5 ± 2.5 a 7.6 ± 0.3 11.2 ± 1.5 
 Necrotic (3) 32.5 ± 5.8 4.2 ± 1.7 7.0 ± 2.9 7.6 ± 2.4 
DEVD Viable (2) 231.0 ± 41.4 a 30.8 ± 3.1 22.2 ± 3.8 21.0 ± 5.5 a 
(1 µM) Apoptotic (5) 350.7 ± 17.2 a 40.0 ± 2.7 a 10.5 ± 2.8 12.9 ± 2.6 
 Necrotic (2) 8.1 ± 5.9 6.3 ± 3.5 7.2 ± 1.5 5.4 ± 1.5 
10 µM Bestatin     
Control Viable (8) 27.7 ± 7.5 29.5 ± 4.2 67.7 ± 9.7 15.4 ± 2.4 
 Apoptotic (16) 33.5 ± 4.6 89.1 ± 10.8 z 138.8 ± 12.5 z 17.2 ± 1.8 
 Necrotic (10) 3.3 ± 0.6 z 4.1 ± 0.5 z 6.8 ± 1.4 z 4.5 ± 0.8 z 
Bestatin Viable (2) 36.5 ± 19.3 20.4 ± 0.3 a 50.5 ± 17.1 18.2 ± 8.4 
(10 µM) Apoptotic (4) 47.1 ± 11.1 131.8 ± 48.7 175.3 ± 55.7 15.3 ± 2.8 
 Necrotic (3) 3.1 ± 1.5 3.9 ± 1.6 8.2 ± 3.8 4.7 ± 1.8 
BB3103 Viable (2) 39.9 ± 13.0 5.4 ± 0.9 a 58.3 ± 10.7 24.9 ± 10.3 
(20 µM) Apoptotic (4) 72.5 ± 12.9 a 9.9 ± 1.2 a 119.4 ± 9.7 a 34.1 ± 9.0 a 
 Necrotic (3) 3.8 ± 1.5 4.4 ± 1.8 7.7 ± 0.3 8.1 ± 3.0 
3AB Viable (4) 11.0 ± 1.5 a 17.9 ± 2.0 a 34.0 ± 3.6 a 11.6 ± 1.7 
(1 mM) Apoptotic (4) 18.3 ± 0.9 a 24.2 ± 5.8 a 56.7 ± 5.7 a 14.8 ± 2.4 
 Necrotic (3) 8.4 ± 3.6 6.5 ± 0.7 14.5 ± 5.2 a 9.6 ± 1.0 a 
DEVD Viable (2) 58.9 ± 9.1 a 58.0 ± 0.2 a 129.4 ± 11.1 a 27.4 ± 1.0 a 
(1 µM) Apoptotic (5) 37.4 ± 12.0 150.0 ± 11.6 a 204.7 ± 26.8 a 15.7 ± 4.5 
 Necrotic (2) 12.1 ± 6.5 a 7.5 ± 4.3 21.8 ± 13.8 a 12.9 ± 9.0 
The significance of differences between control vs. treated subpopulations are represented as a p < 0.05, while 
that between viable vs. apoptotic or necrotic subpopulations of the control groups are represented by z p < 0.05. 
Previously we observed that CSP activity (aminopeptidase and TACE) was increased 2-fold in 
UVC-irradiated cells [22]. Like that seen in the unirradiated cultures, the main CSP present in the  
UVB-irradiated cells was an aminopeptidase (Table 3). With the exception of the 3AB-treated cells 
(87%), the level of aminopeptidase and that of total CSP activity present in the viable subpopulations 
of UVB-irradiated cultures were similar to that seen in the viable subpopulations of unirradiated 
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cultures (Figure 3A). DEVD increased both aminopeptidase and total CSP activity in the viable 
subpopulation of the UVB-irradiated cells when compared to their untreated cohorts. 
Both aminopeptidase and total CSP activity was significantly increased in the apoptotic fraction of 
all the treated UVB-irradiated cells compared to their corresponding viable cell cohorts except for 
those cultures treated with 3AB (Figure 3A). The greatest increase in aminopeptidase and total CSP 
activity between the apoptotic and viable cells of the UVB-irradiated cultures was observed following 
bestatin treatment (240 and 222%, respectively). In neutrophils increased expression of aminopeptidase 
N was seen on the plasma membrane in cells undergoing apoptosis [36]. 
In the UVB-irradiated necrotic cells both aminopeptidase and total CSP activity was significantly 
lower in the necrotic subpopulations when compared to their respective viable or apoptotic cohorts 
(Figure 3A). This result suggests that these CSP have been shed from the cell membrane, which was 
similar to that seen in the necrotic subpopulations of UVC-radiated cells [17]. 
In general, in the UVB-irradiated cultures, the level of ectopeptidase activity was similar in the 
viable subpopulation of the treated cells compared to the same cohort in the unirradiated cultures 
(Figure 3B). Elevated levels of ectopeptidase activity were seen in the viable subpopulation of the 
DEVD-treated (195%) but lower in the 3AB-treated (53%) UVB-irradiated cells compared to their 
corresponding viable cohorts. In those cells undergoing apoptosis, there was a significant increase in 
ectopeptidase activity (150–294%) compared to that seen in the viable subpopulation irrespective of 
the treatment (Figure 3B). The greatest increase in ectopeptidase activity was seen in bestatin-treated 
cells (294%) with the least seen in DEVD-treated cells (150%). Most of this increase was due to 
elevated tripeptidase activity (130–298%). While dipeptidase activity was less than that of tripeptidase, 
its activity also increased in the apoptotic subpopulations (138–383%) of the treated cells compared to 
their corresponding cohorts of viable cells. TACE activity was higher in the apoptotic subpopulation of 
BB3103-treated cells (217%) otherwise its levels of activity were similar to that of its corresponding 
viable cohorts. In the necrotic cells, irrespective of the treatments used, the level of ectopeptidase 
activity was significantly reduced compared to that seen in the viable or apoptotic cell subpopulations 
(Figure 3B). The results obtained were similar to that seen in an earlier study where increased CSP 
activity was observed in cells undergoing apoptosis while there was a loss in activity in the necrotic 
cells [17]. It is not clear as to how DEVD increases or 3AB decreases CSP activity in the viable  
and apoptotic subpopulations of UVB-irradiated cells or that of the necrotic subpopulation of 
unirradiated cultures. 
2.3. Cell Morphology 
In order to elucidate the effect 3AB and DEVD treatments had on CSP activity in the apoptotic cells, 
we looked at their morphology. The effects of the treatments on the morphology of the apoptotic cells 
are seen in Figure 4. Both 3AB and DEVD treatments had no effect on the morphology of  
UV-induced apoptotic cells, as evidenced by the formation of apoptotic bodies and condensation of the 
chromatin to the nuclear membrane [1,3,4]. Of interest was the morphology of Bestatin or  
BB3103-treated apoptotic cells (Figure 4C,D). These cells appear to have morphology similar to that 
of necrotic cells, as no apoptotic bodies appear to be present. There were increased levels of lipid 
droplets present in these cells, and the mitochondria appear extended, however, this morphology was 
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similar to that seen in apoptotic human A549 lung adenocarcinoma cells treated with antisense 
matrilysin oligonucleotides [37]. The effects induced by either 3AB or DEVD on CSP activity in the 
apoptotic cells do not appear to be related to changes in cell morphology.  
Figure 4. Electron micrograph of apoptotic HeLa cells from cultures treated with different 
agents. The cells were treated with the following agents: (A) Sham-irradiated viable cells; 
(B) UVB-irradiated (500 Jm−2) cells; (C) Bes; (D) BB3103; (E) 3AB; and (F) DEVD.  
Bar = 5 µm. 
 
2.4. Annexin V-Staining Profiles 
As the morphology of the 3AB or DEVD-treated UVB-induced apoptotic cells did not differ to that 
of untreated apoptotic cells, we then investigated if the changes in CSP activity was related to 
phosphatidylserine levels on the outside of the cell membrane. Through using FITC-labelled annexin 
V and PI staining, it is possible to distinguish different cell subpopulations as seen in Figure 5. The 
intensity of annexin V-staining of the apoptotic cells was approximately one order of magnitude higher 
than that of their viable cell cohorts, in agreement to that seen previously [38]. 
It was not until 12 h post-UVB radiation that there was a significant increase in the level of annexin 
V-staining occurring on the surface of HeLa cells (results not shown). There was a sharp increase in 
the number of late apoptotic/necrotic cells occurring in the irradiated cells after 12 h, which was 
accompanied by a corresponding drop in the number of viable cells, while the numbers of early 
apoptotic and damaged cells did not change. We also observed that the viability rapidly dropped in 
cultures exposed to >100 Jm−2 UVB 20 h post-irradiation (Results not shown), which was similar to 
that seen when the cells were stained with PI and H33342 (Figure 1). 
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Figure 5. Separation of HeLa cell subpopulations by flow cytometry. The different 
subpopulations of cells are R1 = Viable cells, R2 = Early Apoptotic cells, R3 = Late 
Apoptotic/Necrotic cells and R4 = Cell debris. 
 
The effect of the different treatments on phosphatidylserine eversion on the cell membrane in 20 h 
post UVB-irradiated cultures is seen in Figure 6. Cells treated with bestatin, BB3103 and DEVD had 
similar annexin V/PI staining profiles compared to that seen in the untreated irradiated cultures. There 
was an elevated number of viable cells and a corresponding reduced number of late apoptotic/necrotic 
cells in the 3AB-treated cultures. However, these differences were not statistically different and did  
not correspond to the changes in the level of CSP activity observed in either the 3AB- or  
DEVD-treated cultures.  
Figure 6. Effect of different agents on annexin V-staining of UVB-irradiated HeLa cell 
cultures. UVB-Irradiated (500 Jm−2) cells were exposed to different agents (UVB radiation 
(UVB), Bestatin (Bes), BB3103 (BB), 3-aminobenzamide (3AB) and DEVD). The 
different cell subpopulations were: Viable (□), Early apoptotic ( ), late apoptotic/necrotic (■) 
and Cell debris ( ). Results expressed are the mean ± SEM of 3 separate experiments. The 
statistical significance of the difference between the % total cell subpopulation between the 
untreated controls and each treatment group is represented as * p < 0.05.  
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2.5. PARP Cleavage 
3AB is known to inhibit PARP activation in cells suffering oxidative stress [20,39]. We therefore 
decided to see if 3AB affected the cleavage of PARP by the caspases, which could explain the 
differences in CSP activity observed in the treated cultures. Cell lysates from the viable, apoptotic and 
necrotic subpopulations of UVB-irradiated cells treated as well those from the viable subpopulation of 
unirradiated cells treated with different agents were prepared from Flow cytometry-sorted cells. A 
Western blot of the cell lysates (20 µg cell protein) is seen in Figure 7. In the viable fraction of the 
unirradiated cells PARP remained intact 20 h-post treatment, irrespective of treatment. Similar results 
were also seen in the viable subpopulations of the UVB-irradiated cells. However, in both the 
apoptotic and necrotic fractions of these treated cell populations PARP (115 kD) was cleaved to its  
86 kD product. The caspase 3 inhibitor DEVD did not prevent PARP from being cleaved, which 
suggests that other caspases such as caspase 7 may be present [11,21]. The addition of 3AB to the 
UVB-irradiated cells did not prevent PARP cleavage in the apoptotic cells, which suggests that the 
activation of CSP activity is not mediated by caspase 3. 
Figure 7. Effect of different agents on PARP cleavage in different fractions of irradiated 
HeLa cell cultures. UVB-irradiated cells (0 Jm−2 or 500 Jm−2) were treated with the 
following agents: nothing (controls: Con), bestatin (Bes), BB3103 (BB), 3AB and DEVD. 
Lysates of sorted viable subpopulations of unirradiated cultures (A); and UVB-irradiated 
cultures (B) along with the apoptotic subpopulations of UVB-irradiated cultures (C) were 
prepared as described in the Materials and Methods section. Jurkat cell lysates (Std) were 
added to each gel. In the 500 J Viable blot 40 µg cell lysate was added per lane while in the 
other blots 20 µg was added. GAPDH was used as a loading control. Molecular mass 
markers in kD are indicated on the right. 
 
2.6. Caspase 3 Activity 
As PARP was cleaved in apoptotic cells treated with DEVD, we then measured the level of caspase 
3 activity in the 20 h post-UVB irradiated cultures, in order to confirm if other caspases are present. 
Initial studies using flow cytometry-sorted cells were unsuccessful as it was not possible to obtain 
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sufficient numbers of cells in a short period of time to be able perform this assay. We used cells 
obtained from UVB-irradiated cultures treated with different agents, as this would give an indication of 
the level of caspase 3 activity present. The results of which are seen in Figure 8. As expected the level 
of caspase 3 activity was low in the untreated sham-irradiated cultures and much higher in untreated 
UVB-irradiated cells. Neither bestatin or 3AB treatment had an effect on caspase 3 activity, while 
BB3103 significantly increased and DEVD significantly inhibited activity. The DEVD result was 
expected as it is a caspase 3 inhibitor [10,11]. The results suggest that other caspases (e.g. caspase 7) 
may be responsible for the cleavage of PARP in these cells (Figure 7). It also suggests that caspase 3 
does not directly modulate CSP activity in cells undergoing UVB-induced apoptosis. 
Figure 8. Effect of different agents on caspase 3 activity in irradiated HeLa cell cultures. 
The level of caspase 3 activity was measured in sham-irradiated untreated cultures (0 J Con) 
(■), and in UVB-irradiated cultures treated with nothing (500 J Con) (□), 10 µM Bes ( ), 
20 µM BB3103 ( ), 10 mM 3AB ( ) and 1 µM DEVD ( ). Results expressed are the 
mean ± SEM of 3 separate experiments. The statistical significance of the difference 
between caspase 3 activity in the control population and in each treated group is 
represented as * p < 0.05. 
 
2.7. Actin Cleavage 
It has been shown that 3AB prevents actin cleavage, which confers a protective effect to cells 
preventing them from undergoing apoptosis [10,25]. A Western blot of cell lysates from the apoptotic 
subpopulation of 20 h post-UVB irradiated cell cultures was probed with an actin antibody as seen in 
Figure 9. In the apoptotic subpopulation of the treated UVB-irradiated cells the 43 kD actin protein 
was cleaved to produce 38 and 31 kD actin fragments, but the 14 kD fragment was not observed in 
cultures treated with either 3AB or DEVD. Actin degradation was not seen in the viable untreated 
irradiated cells. These results suggest that the changes in CSP activity seen in the cells as they undergo 
apoptosis is not due to actin cleavage, because 3AB-treatment reduced CSP activity, while that of 
DEVD enhanced activity, but both elicited the same inhibitory effect on actin cleavage. This suggests 
the mechanism involved in modulating CSP activity in these cells undergoing UVB-induced apoptosis 
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does not involve caspase 3, PARP or actin cleavage, and occurs by another mechanism. Further studies 
on which are currently underway. 
Figure 9. Effect of different agents on the cleavage of actin in the apoptotic population of 
irradiated HeLa cell cultures. Lysates from the sorted apoptotic subpopulations of treated 
(controls (Con), bestatin (Bes), BB3103 (BB), 3AB and DEVD) (A) or the viable 
subpopulation (Via) of untreated 500 Jm−2 UVB-irradiated cultures (B) were run on 
Western blots. GAPDH was used as a loading control. Molecular mass markers in kD are 
indicated on the right. 
 
3. Discussion 
Ultraviolet (UV) light is a form of electromagnetic radiation that is emitted by the sun. It can be 
subdivided into three components, based on wavelength: UVC (200–280 nm), UVB (280–320 nm) and 
UVA (320–400 nm). Most of the UV radiation that reaches the Earth’s surface consists of UVA  
(320–400 nm) (90–95%) along with a smaller amount of UVB (280–320 nm) (5–10%). While only a 
small amount of UVB reaches the Earth’s surface, it is of significance as it is 1000 times more 
erythrematogenic than UVA [40]. UV radiation that is absorbed by epidermal cells (e.g., keratinocytes 
and melanocytes) triggers a number of signalling pathways, which in turn elicits different cellular 
responses [40,41]. Sunburn is caused by keratinocytes undergoing apoptosis as a result of high levels 
of UV exposure [1,2,23,39,40]. While many intracellular processes are altered as a result of these cells 
undergoing apoptosis, changes that occur on the cell membrane with regard to enzyme activity are not 
well characterized.  
Even though HeLa cells are not an epidermal cell, they are epithelial in origin, and like HaCaT cells 
(an immortalized keratinocyte cell line), they possess a dysfunctional p53 [42,43]. In human skin p53 
mutations are commonly observed in the sun-exposed noncancerous epidermis, and it is from these 
mutated cells that squamous cell carcinomas (SCC) have been shown to develop [44]. In keratinocytes 
that have a functional p53, excessive exposure to UV radiation results in these cells undergoing 
apoptosis [1,2,45]. As a result of UV-induced DNA damage p53 is activated, which in turn upregulates 
p21 levels and through downstream signalling the cell will undergo apoptosis if this damage cannot be 
repaired [45]. If p53 is mutated, p21 activation is much weaker, and as a result fewer irradiated cells 
undergo apoptosis, and those surviving cells have the potential to become cancerous. Therefore in 
order to observe the effect of UVB radiation in squamous cell carcinoma development, keratinocytes 
that harbour p53 mutations such as HaCaT cells are a good experimental model [44,45]. As the 
numbers of cells needed to undertake a study of CSP activity are high, and their separation requires 
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flow cytometry to collect cells from viable, apoptotic and necrotic subpopulations, we used HeLa cells 
in this study. These cells can easily be grown in large numbers and like HaCaT cells they possess a 
dysfunctional p53 [42,43]. The results obtained from this study can be used to devise further 
experiments using HaCaT cells which will allow us to understand the role played by mutated 
keratinocytes (possessing a dysfunctional p53) found in actinic keratosis [46] following their exposure 
to UV radiation.  
We had shown previously that cycloheximide did not inhibit enhanced CSP activity in apoptotic 
cells [17], which suggested that increased activity was not due to de novo synthesis and this activation 
was by another mechanism. Therefore, in order to further our understanding of this mechanism, we 
investigated the effect different inhibitors had on UVB-induced apoptotic cells. Bestatin inhibits a 
range of aminopeptidases as well as Leukotriene A4 hydrolyase [24,35]. The cells were incubated with 
bestatin in order to observe if aminopeptidases activate CSP as a result of the cells undergoing 
apoptosis. BB3103 is a MMP inhibitor and was added to the cells to observe if these membrane 
proteins activate CSP activity. 3AB prevents the activation of PARP, and it was used to observe if 
PARP activation played a role in modulating CSP activity. DEVD is a caspase 3 inhibitor as was used 
to see if caspase activity modulated CSP activity, we have previously shown that ICE (caspase 1) 
found on the cell membrane had no effect on activity [17].  
The viability profiles of HeLa cells exposed to UVB and UVC radiation differed (Figure 1) and 
were probably a result of different apoptotic pathways being activated in the cell. UVC radiation 
generated more (6–4) photoproducts and cyclobutane-pyrimidine dimers than did UVB in HaCaT cells 
[23] and it is likely that this occurred in the irradiated HeLa cells. It has been shown in keratinocytes 
and HaCaT cells, UVB radiation can initiate apoptosis by three major mechanisms (a) DNA damage, 
(b) reactive oxygen species (ROS) and (c) the activation of death receptors [1,2,23,44]. UVC mainly 
exerts its apoptotic effect by initiating DNA damage. The pathway by which UVC induces apoptosis is 
called the intrinsic pathway and it differs from the extrinsic pathway induced by UVB, because it does 
not involve caspase 8 and related caspases which is stimulated as a result of the activation of death 
receptors (e.g., Fas) on the cell membrane [23,47]. A unique feature of the extrinsic pathway is that it 
can trigger apoptosis independently of p53 [48]. Therefore it is likely that the differences seen in HeLa 
cells undergoing apoptosis as a result of UVC [17] and UVB radiation (Figure 1) are due to the 
different apoptotic pathways (intrinsic and extrinsic) that are activated by these forms of UV radiation. 
The main peptidase found on the plasma membrane of the HeLa cells was an aminopeptidase 
(Figure 3). In the unirradiated cultures the level of CSP activity was similar in the viable and necrotic 
subpopulation of cells. This suggests that there has been neither an upregulation of CSP activity nor a 
shedding of these peptidases from the cell membrane as a result of the cell dying. If aminopeptidase 
activity was inhibited by the addition of bestatin, a specific aminopeptidase inhibitor, the overall level 
of CSP was similar which suggests that the ectopeptidase products (P2, P3 and P5) are further 
degraded by the action of the aminopeptidase. Aminopeptidases found on the cell membrane process a 
range of substrates, and play a role in many biological processes, as well as disease states [35,49]. 
They can also cleave the N-terminal amino acid from peptides or proteins, which can then in turn be 
taken up by the cell via specific transporters as part of a salvage type mechanism [30,35,50]. The 
actions of which can also allow the cell to obtain essential amino acids from the cleavage of peptides 
and proteins on the plasma membrane. 
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In the UVB-irradiated cells enhanced CSP activity was not seen in the viable cell subpopulation, 
unlike that seen in the apoptotic subpopulation where it was increased, and reduced in the necrotic 
subpopulation (Figure 3). This finding suggests that UVB-radiation does not have an effect on CSP 
activity as no increase in activity was observed in the viable cells, and the increased activity seen in 
apoptotic cells arises when these cells undergoing apoptosis. Of interest was that 3AB treatment 
reduced CSP activity, while that of DEVD enhanced activity in both the viable and apoptotic 
subpopulations of the UVB-irradiated cells. Bestatin only enhanced CSP activity in cells undergoing 
apoptosis, while BB3103 had no effect. This increase in CSP activity in the apoptotic subpopulation 
compared to the viable subpopulation is not related to changes in cell protein levels (Table 1) as if this 
was the case enzyme activity would only be increased 1.25-fold. Increased CSP activity as high of  
2.2-fold was observed in the apoptotic subpopulations compared to the viable subpopulations of the 
irradiated cells. As the increase in CSP activity was not uniform across all treatments, this suggests 
that it is not part of a global apoptotic response. In a previous study we observed increased CSP 
activity in cycloheximide-induced apoptotic cells, which suggests that this increased activity is not due 
to the synthesis of new proteins in these cells [17]. Increased CSP activity may arise from an activation 
of existing enzymes on the cell membrane or as a result of increased translocation of enzymes from the 
cytoplasm to the plasma membrane, in an analogous manner to how insulin stimulates the relocation of 
GLUT-4 transporters from the cytoplasm to the plasma membrane [51]. 
The reduction in CSP activity in the necrotic cell subpopulation (Figure 3), suggests that these 
enzymes are shed from the cell membrane as the cells undergo necrosis. It has been shown previously 
that UVC-induced necrosis resulted in a loss of cellular protein and a corresponding loss of CSP 
activity [17]. It has been shown that a range of pro-inflammatory molecules (e.g., IL-6, uric acid) are 
shed from the surface of necrotic cells [52]. It is not known if proteases released from the surface of 
necrotic cells directly contribute to the release of pro-inflammatory molecules or may contribute to the 
dissolution of matrix components surrounding these cells.  
The increase in CSP activity observed in cells undergoing apoptosis most likely has a specific 
physiological function. Some of the membrane proteins shed from apoptotic cells include cytokines 
(IL-1β and TNFα), adhesion molecules (e.g., E-cadherin and L-selectin), receptors (CD15, CD16, 
IL6R, TNF-R1 and TNF-R2) as well as other proteins (e.g., CD46) [13–15,34,36,53]. Some of these 
molecules are known to attract phagocytic cells to ensure the removal of the apoptotic bodies, as well 
as downregulating an inflammatory response. While these proteins are shed during the apoptotic 
process, it is unknown whether the activities of the enzymes involved are either (a) upregulated or (b) 
there are increased numbers present on the cell membrane. Apart from that of caspase 1 [10,11], both 
aminopeptidase N [36] and TACE activity [15] have been shown to be increased in apoptotic 
neutrophils, along with that of CSP in UVC-induced apoptotic HeLa cells [17]. As seen in this study 
the level of enzyme activity increased from 1.5-2.2-fold for each of the peptidases that were 
investigated. This increased level of CSP activity may result in the release of bioactive molecules 
which can (a) assist in attracting phagocytic cells to remove the resultant apoptotic cells, (b) reducing 
inflammation, as well as (c) stimulating the growth of surrounding unaffected cells to replace those 
which have died. The latter could be one mechanism by which surviving epidermal keratinocytes are 
stimulated to grow and replace those sunburnt cells lost as a result of UV exposure [39,40,54]. Cell 
surface proteases have been shown to play an important role in wound repair and tissue growth [55], 
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and one can speculate that following the loss of sunburnt cells, that these proteases as a result of being 
activated would be involved in stimulating tissue growth in these cells, and this process would most 
likely commence when these cells undergo apoptosis. 
The caspase 3 inhibitor Ac-DEVD-cho enhanced CSP activity in the necrotic subpopulation  
of unirradiated cultures as well as that of the viable and apoptotic subpopulations of UVB-irradiated 
cells (Figure 3). Caspase 3 is an executioner caspase and is known to cleave over 200 cellular  
proteins [10,11,56]. It is estimated through the use of bioinformatics that there are at least 3000 human 
proteins that contain a caspase 3 cleavage site [56]. The inhibitor Ac-DEVD-cho was shown to inhibit 
caspase 3 activity (Figure 8) and therefore one can speculate that this enzyme may cleave protein(s) 
that regulate the activation of the CSP observed in this study. As both the aminopeptidase and 
ectopeptidases were activated in the necrotic subpopulation of the unirradiated cultures as well as that 
of the viable and apoptotic subpopulations of the UVB-irradiated, it is unlikely that this activation is 
related to the activation of apoptotic pathways, but occurs via another unknown mechanism. Pan 
caspase inhibitors such as Z-VAD-FMK and Q-VD-OPH, when added in combination have been 
shown to inhibit most of the caspases in the cell [57]. The results of such a study would confirm if the 
activation of CSP seen in the apoptotic cells is related to that of the caspases.  
The PARP activation inhibitor 3AB [19–21] elicited an opposite effect to that of DEVD with 
regards to CSP activity in these cells (Figure 3). 3AB significantly reduced CSP activity in the necrotic 
subpopulation of unirradiated cultures as well as in the viable and apoptotic subpopulation of  
UVB-irradiated cultures. When PARP becomes activated it is involved in repairing damaged DNA, 
and requires NADH to be able to effect this repair [19–21]. When the cell suffers significant DNA 
damage, in this case UVB radiation, in order to prevent the depletion of NADH stores which will result 
in the cell undergoing necrosis, and resultant inflammation, the cell initiates the caspase cascade. This 
result in the cleavage of PARP, preventing the depletion of cellular NADH stores, resulting in the cell 
undergoing apoptosis, and reducing the inflammatory response. PARP inhibitors at high concentrations 
(10 mM) have been shown to inhibit matrix metalloprotease 2 (MMP-2) activity on the cell  
membrane [58]. MMP-2 is a metalloprotease, and the enzyme furin is responsible for its activation [59], 
one can speculate that 3AB inhibits the activity of this proprotein convertase, resulting in the reduced 
expression of this metalloprotease on the cell membrane. In the current study it is possible that 3AB 
inhibits either the activation or expression of CSP on the surface of these cells. In order to understand 
how 3AB is exerting its effects further studies are warranted. A measure of the cellular NADH levels 
as well as that of PARP activity may shed some light on whether CSP activation is energy dependent, 
this may elucidate why 3AB and DEVD treatment results in differing levels of CSP activity in the cell. 
The use of other structurally distinct PARP inhibitors (e.g., PJ34, 1,5-isoquinolinediol) may also help 
elucidate the role PARP plays in modulating CSP activity.  
When investigating the mechanism by which DEVD or 3AB affect CSP activity, we observed that 
changes in the level of phosphatidylserine eversion on the cell membrane (Figure 6) did not correlate 
to the observed changes in CSP activity. The gross morphology of the apoptotic cells treated with 
DEVD and 3AB was also similar to that seen for untreated apoptotic cells (Figure 4). These findings 
suggest that changes in CSP activity are not due to changes in cellular morphology or that of lipids on 
the cell membrane. The morphology of the apoptotic cells obtained from cultures treated with bestatin 
and the metalloprotease inhibitor BB3103 does not appear to contain apoptotic bodies. It has been 
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shown that MMP-7 inhibition resulted in altered morphology of apoptotic cells where the mitochondria 
were swollen and the endoplasmic reticulum was dilated [37]. Recently it has been shown that in some 
cells swelling precedes cell shrinkage and the formation of apoptotic bodies [60]. The bestatin and  
BB3103-treated apoptotic cells in this study display a similar morphology as described above, and the 
mechanism involved in the apoptotic pathway of these cells where enzyme inhibitors have been used 
could be responsible for these morphological changes.  
In all the apoptotic treated cells PARP was shown to be cleaved (Figure 7), and while the caspase 3 
inhibitor, DEVD, inhibited activity (Figure 8), it suggests that other caspases are involved in this 
process. Caspase 7 can also cleave PARP [10,11], and is known to be activated in UV-irradiated HeLa 
cells [61]. Therefore the activation of caspase 7 as a result of UV radiation can overcome the inhibition 
of caspase 3 and result in the cleavage of PARP as seen in the DEVD-treated cells. Changes in caspase 
3 activity (Figure 8) did not correlate to the changes seen in the level of CSP activity in these cells 
(Figure 3). This suggests that this caspase does not play a direct role in modulating CSP activity. Of 
interest is that the level of actin cleavage in the treated apoptotic cells was less in the 3AB- and 
DEVD-treated cells compared to that seen in other treated cells. Caspase 3 is known to cleave actin to 
smaller fragments and 3AB can prevent cleavage [25]. DEVD inhibits the action of caspase 3, and it 
suggests that it plays a role in cleaving this cytoskeletal protein [10,11]. This finding supports the 
proposal that caspase 3 is not involved in the changes of CSP activity in those cells undergoing 
apoptosis. However the mechanism involved does warrant further investigation. 
The results of this study show that in general, when UV-irradiated cells undergo apoptosis, that 
there is an increase in CSP activity and it is not related to caspase 3 activity. While HeLa cells are 
epithelial cells they are not epidermal in origin like keratinocytes. It has been shown that primary 
keratinocytes have a functional p53, while HaCaT cells [1,2,44,45] and HeLa cells [42] do not. The 
resultant DNA damage induced by UV radiation on keratinocytes results in the activation of p53, 
which in turn induced p21 expression in the cell, which prevents these cells from entering the S phase 
of the cell cycle [45]. If the level of damage is too great to repair, p53 will induce the cell to undergo 
apoptosis [44]. This mechanism removes those cells with damaged DNA thereby preventing them 
from passing on these defects to daughter cells, which could result in the formation of SCC [44]. As a 
result of prolonged sun exposure actinic keratoses are formed in the epidermis which contain mutated 
p53 [46], which can give rise to SCC [44]. HaCaT cells are similar to the actinic keratoses in that they 
also have a dysfunctional p53, and that they would be a good model in which to investigate the 
carcinogenic effects of UV radiation. From the results obtained in this study one can speculate that 
when actinic keratoses undergo UV-induced apoptosis, they may release a range of bioactive molecules, 
which stimulate the growth of the surrounding surviving mutated cells. If these dividing cells pass on 
UV-induced DNA mutations, this process if repeated a number of times may result in the development 
of a SCC. Further investigation on the effect UV radiation on CSP activity in both UV-irradiated 
HaCaT cells and keratinocytes may yield information on the biological role cell surface proteases play 
in this process. As a result of the development of pharmacological agents that prevent the activation of 
these CSP, these agents may play an important preventative role in the formation of skin cancer. 
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4. Experimental Section 
4.1. Materials 
All chemicals and biochemicals were obtained from sources previously described [17,22] except for 
caspase 3 substrate N-acetyl-Tyr-Val-Ala-Asp-p-nitroanilide (Ac-DEVD-pNA), 3-Aminobenzamide 
(3AB) and the cell permeable inhibitor N-acetyl-Tyr-Val-Ala-Asp-CHO (DEVD) which were obtained 
from Biomol (Plymouth Meeting, PA, USA), rabbit anti-actin polyclonal antibody was obtained from 
Sigma (St. Louis, MO, USA) rabbit anti-GAPDH (glyceraldehyde-3 phosphate dehydrogenase) 
monoclonal antibody was obtained from Cell Signaling (Danvers, MA, USA), Jurkat apoptotic lysate 
kit, fluorescein isothiocyanate-labelled Annexin V and mouse anti-human PARP monoclonal antibody 
were obtained from PharMingen (San Diego, CA, USA), anti-mouse Ig-peroxidase conjugate was 
obtained from Transduction Laboratories (Lexington, KY, USA), anti-rabbit Ig-peroxidase conjugate 
antibody was obtained from Silenus (Melbourne, Australia) and ECL was obtained from NEN (Boston, 
MA, USA). 
4.2. HeLa Cell Culture 
HeLa S3 cell monolayers were grown in RPMI 1640 containing penicillin (100 µg/mL), 
streptomycin (100 µg/mL), Hepes (20 mM) and 5% (v/v) foetal bovine serum (FBS) (pH 7.2 at 37 °C) 
under sterile conditions. Trypsinised cells from 3–4 confluent 175 cm2 tissue culture flasks were 
collected and washed with Phenol red free-HBSS prior to being suspended at 107 cells/mL HBSS. One 
ml aliquots of cells (107) were transferred to 60 mm tissue culture dishes (Iwaki Glass, Chiba, Japan) 
which were subsequently irradiated with either 0 or 500 J UVB (FS-20 fluorescent tube generating a 
flux of 2.1 Jm−2/s). The cells were then transferred to a 175 cm2 flask containing 50 mL RPMI plus 2% 
FBS as well as one of the following inhibitors: no inhibitor (control cells), Bestatin (10 µM), BB3103 
(20 µM), DEVD (1 µM) or 3AB (10 mM). In the caspase 3 inhibition studies, the cells were  
pre-exposed to DEVD for 60 min prior to irradiation to ensure that caspase 3 activity was minimal [27]. 
The cells were placed in a 37 °C incubator for 20 h before being harvested for FACS analysis. 
4.3. Preparation of Cells for Sorting by Flow Cytometry 
The detached cells present in tissue culture media of the treated cultures were transferred to 50 mL 
Falcon tubes. The attached cells were removed by trypsinization and placed in the same tubes and the 
samples treated as described previously [17]. Briefly, following centrifugation (37 °C at 200 g for  
5 min) the cells were resuspended at 37 °C in 5 mL RPMI containing 2% FBS. The cell populations 
were then stained with H33342 (1 µg/mL final concentration) for 15 min before being placed on ice 
for 5 min before being centrifuged (4 °C at 200 g for 5 min). The cells were resuspended at 4 °C in  
1 mL RPMI containing 2% FBS to which PI (5 µg/mL final concentration) was added. The cells were 
passed through gauze into 5 mL Falcon tubes prior to being sorted on a Becton Dickinson FACS 
Vantage. The number of cells found in each fraction was determined using the Cell Lysis analysis software. 
  
Int. J. Mol. Sci. 2012, 13 2669 
 
 
4.4. Flow Cytometry 
The stained cells were separated into viable, apoptotic and necrotic populations on the basis of their 
staining for PI and H33342 dyes as described previously [17]. The characteristic of staining patterns 
for the different cell subpopulations were as follows: viable cells possess low H33342 and PI staining, 
apoptotic cells had a high H33342 and low PI staining, and necrotic cells have high H33342 and PI 
staining (see Figure 1 [17]). The membrane integrity of early apoptotic cells prevent the entry of PI, 
and while H33342 binds to the DNA during this period it allows for the cell subpopulations to be 
distinguished [28,34,62]. The sorted cell subpopulations of UVB-irradiated cells displayed the 
following characteristics: viable cells possessed intact DNA, apoptotic cells laddered DNA and 
necrotic cells smeared DNA (Results not shown), which was similar to that seen previously [17]. The 
morphological characteristic of these irradiated subpopulations were as follows: viable cells (>95%) 
has an intact plasma membrane and no nuclear chromatin condensation, apoptotic cells (90–95%) 
possessed apoptotic bodies and condensed chromatin on the plasma membrane, while the necrotic cells 
(>95%) possessed disrupted plasma membrane and little visible chromatin (Results not shown), which 
was similar to that seen previously [17]. The sorted cell populations were centrifuged (200 g for 5 min 
at 4 °C) before being washed twice with ice cold HBSS. The sorted cell subpopulations were washed 
to remove any serum present in the collection medium, as FBS displays some protease activity [22]. 
After the final wash, the cells were suspended at 106 cells/mL HBSS and 50 µL aliquots placed in 
microfuge tubes. These tubes were placed in a 37 °C incubator for 15 min to warm the cells prior to 
being assayed for CSP activity. 
4.5. Electron Microscopy 
The sorted cell populations were centrifuged (200 g for 5 min at 4 °C) before being washed with 
ice-cold HBSS. The cell pellets were fixed in 3% glutaraldehyde in 0.1 M sodium cacodylate buffer, 
pH 7.2 for 2 h. The samples were then post-fixed in 1% osmium tetroxide, stained “en block” with 5% 
uranyl acetate then embedded in epoxy resin. Sections were taken and observed in a Joel 1200 EXII 
electron microscope. 
4.6. Annexin V Staining 
HeLa cell cultures were grown to near confluency in 60 mm petri dishes (Iwaki Glass, Chiba, Japan) 
prior to being exposed to different doses of UVB-irradiation as described above. The cells were then 
given fresh media (RPMI plus 5% FBS) and inhibitors (the final concentrations are listed in the 
Results section). At the end of the exposure period the detached cells present in the culture media was 
removed and placed in a test tube. The adhered cells were detached using trypsin and were combined 
with the detached cells. The cells were centrifuged (200 g for 5 min at 20 °C) and washed with PBS to 
remove any excess media. The cells were then suspended in 100 µL incubation buffer (10 mM Hepes, 
140 mM NaCl and 5 mM CaCl2, pH 7.4) containing 4 µL fluorescein isothiocyanate-labelled annexin 
V for 15 min at room temperature. Then 400 µL incubation buffer plus 10 µL PI (50 µg/mL) was 
added to the cells, which were filtered through gauze prior to being analysed on a Becton Dickinson 
FACScan, flow cytometer. 
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4.7. Western Blot Assay 
The sorted cell subpopulations (viable, apoptotic and necrotic) from the treated cultures were 
collected and washed free of collecting media as described above. Cell lysates were prepared by 
resuspending 106 cells/200 µL NETN (20 mM Tris pH 8.0, 1 mM EDTA, 100 mM NaCl, 0.5% NP-40) 
supplemented with 300 mM NaCl and 5 µg/mL leupeptin, pepstatin A and aprotinin and 0.5 mM 
PMSF for 15 min at 4 °C. The lysate supernatants were diluted 1:5 with 5X SDS sample buffer and 
boiled for 3 min. Samples containing 20 µg protein were loaded onto 10% SDS-PAGE gels, then 
blotted onto nitrocellulose filters (Amersham Pharmacia Biotech, Amersham, UK) using semi-dry 
electrotransfer. In order to resolve the cleaved bands of PARP, 5 µg lysates from the Jurkat apoptotic 
lysate set were run in each Western blot. After transfer the membranes were blocked in 5% blotto (0.1% 
Tween 20 in PBS containing 5% skim milk powder) for 2 h and then incubated in primary antibody 
overnight at 4 °C using either anti PARP antibody, anti-actin antibody or anti-GADPH antibody 
diluted in 1% blotto. The next day, the membranes were given three 10 min washes in PBS plus 0.1% 
Tween 20 buffer, before being incubated in either anti-mouse Ig-peroxidase conjugated (in case of 
anti-PARP Western) or anti-rabbit Ig-peroxidase conjugated (in case of anti-Actin and anti-GAPDH 
Westerns) at room temperature for 2 h. GAPDH was probed in these blots to show the levels of protein 
in each lane. The membranes were then given three 10 min washes in PBS plus 0.1% Tween 20 buffer, 
prior to the bands being visualised using ECL as per the manufacturer’s instructions. 
4.8. Peptidase Activity 
The P9 nonapeptide (YVAAAVVSH), which is cognate to the N-terminal cleavage site of 
preproTGFα, was labelled with 125I as previously described [29]. The rate of P9 hydrolysis by the 
sorted cell populations was assayed as follows: 20 µL of labelled P9 (1 µL 125I-P9 (10 pmoles) in  
20 µL HBSS) was added to a 1.5 mL microfuge tube along with 50 µL of FACS sorted cell population 
(prewarmed to 37 °C for 15 min) for 15 min (P9 final concentration 140 nM). The aminopeptidase 
inhibitor bestatin [24] was added to the assay to a final concentration of 10 µM. At the end of the 
experiment 40 µL of the reaction mixture was spotted on a multichannelled TLC plate. The plates were 
dried and the peptide fragments separated by ascending chromatography [butanol:H2O:acetic acid, 
100:30:10, pH 2.6], then imaged and analysed by phosphorimaging analysis as previously  
described [22]. 
4.9. Caspase 3 Activity Studies 
HeLa cell cultures were grown to near confluency in 60 mm petri dishes prior to being exposed to 
different doses of UVB-irradiation as described above. The cells were then given fresh media (RPMI 
plus 5% FBS) and inhibitors (final concentrations listed in the Results section). After 20 h, the 
detached cells present in the culture media was removed and placed in a test tube. The adhered cells 
were detached using trypsin and were combined with the detached cells. The cells were centrifuged 
(200 for 5 min at 20 °C) and washed with prior to being lysed in 1 mL lysis buffer (10 mM Hepes, 0.1% 
CHAPS, 5 mM DTT, 2 mM EDTA and 1 mM PMSF, pH 7.25) by sonication. Following 
centrifugation (2 min at 8500 g), 10 µL of the cell supernatant along with 0.2 mM DEVD-pNA and 
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caspase reaction buffer (100 mM Hepes, 10% sucrose, 5 mM DTT, 0.1% CHAPS, pH 7.25) to a final 
volume of 100 µL. Assays were incubated at 37 °C and the changes in absorbance levels at 415 nm 
were measured over 3 h. Specific activity was calculated as the amount of enzyme that hydrolyzes  
1 nmol substrate/h per mg cell protein. 
4.10. Calculations 
The pmoles of P9-derived peptides separated by TLC were quantified using phosphorimage 
analysis. The rates of P9 hydrolysis were expressed as a function of cellular protein levels. The 
significance of differences due to apoptotic agents on the hydrolysis of P9 by HeLa cell subpopulations 
was determined using Student’s t-test, and Bonferroni’s adjustment of this analysis when necessitated 
by multiple comparisons. 
5. Conclusions  
UVB radiation causes an increase of CSP activity in HeLa cells that are undergoing apoptosis, 
while there was a loss of activity in those cells that underwent necrosis. The most active peptidase 
found on the cell membrane was an aminopeptidase. This increase in CSP activity was not due to 
activation of caspase 3, PARP cleavage, eversion of phosphatidylserine on the cell membrane, nor due 
to the cleavage of actin in the cell cytoskeleton. CSP activity was not activated in the apoptotic cells 
when the PARP inhibitor 3-aminobenzamide was added to the cultures, but was activated in the 
presence of the caspase 3 inhibitor (DEVD), though the mechanism(s) involved is/are unknown. 
Through further examination of the mechanism by which CSP activity is elevated in UV-irradiated 
skin cells undergoing apoptosis, it may be possible to devise inhibitors that can reduce the release of 
bioactive molecules from these cells, which may stimulate the growth of damaged cells, thereby in turn 
reducing the development on skin cancers.  
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